Femoral venous catheterization. Does it really need to be avoided?;Cateterización venosa femoral: ¿realmente hay que evitarla?

Medicina Intensiva

Volumn 33, Issue 9, 2009, Pages 442-449

  Lorente, L ^a   Leon C ^b  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

Bacteremia; Catheter; Femoral; Impregnated

Indexed keywords

ANTIINFECTIVE AGENT; CHLORHEXIDINE; MICONAZOLE; MINOCYCLINE; RIFAMPICIN; SULFADIAZINE;

ARTICLE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; FEMORAL VEIN; GAS EMBOLISM; HEALTH EDUCATION; HEMATOTHORAX; HUMAN; INFECTION PREVENTION; INFECTION RISK; PNEUMOTHORAX; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; SUBCLAVIAN VEIN; VEIN THROMBOSIS;

ANTI-INFECTIVE AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; ARTERIES; BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; FEMORAL VEIN; HEMOTHORAX; HUMANS; PNEUMOTHORAX; PRACTICE GUIDELINES AS TOPIC; RISK; SPAIN; STRESS, MECHANICAL; SUBCLAVIAN VEIN; UNNECESSARY PROCEDURES; VENOUS THROMBOSIS;

EID: 70449099307     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2009.03.009     Document Type: Article

References (79)

1. Vaqué J., Rosselló J., Arribas J.L., and EPINE Working Group. Prevalence of nosocomial infections in Spain: EPINE study 1990-1997. EPINE Working Group. J Hosp Infect 43 (1999) S105-S111
2. Vincent J.L., Bihari D.J., Suter P.M., Bruining H.A., White J., Nicolas M.H., and the EPIC International Advisory Committee. The prevalence of nosocomial infection in Intensive Care Units in Europe. JAMA 274 (1995) 639-644
3. Bozzetti F., Terno G., Camerini E., Baticci F., Scarpa D., and Pupa A. Pathogenesis and redictability of central venous catheter sepsis. Surgery 91 (1982) 383-389
4. Collignon P., Soni N., Pearson I., Sorrell T., and Woods P. Sepsis associated with central vein catheters in critically ill patients. Intensive Care Med 14 (1988) 227-231
5. Richet H., Hubert B., Nitemberg G., Andremont A., Buu-Hoi A., Ourbak C., et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter culture in intensive care unit patients. J Clin Microbiol 28 (1990) 2520-2525
6. Mermel L.A., McCormick R.D., Springman S.R., and Maki D.G. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: A prospective study utilizing molecular subtyping. Am J Med 91 (1991) 197S-205S
7. Kemp L., Burge J., Choban P., Harden J., Mirtallo J., and Flancbaum L. The effect of catheter type and site on infection rates in total parenteral nutrition patients. J Parenter Enteral Nutr 18 (1994) 71-74
8. Moro M.L., Vigano E.F., and Cozzi A. Risk factors for central venous catheter-related infections in surgical and intensive care units. The Central Venous Catheter Related Infections Study Group. Infect Control Hosp Epidemiol 15 (1994) 253-264
9. Durbec O., Vivand X., Potie F., Vialet R., Albanese J., and Martin C. A prospective evaluation of the use of femoral venous catheters in critically ill adults. Crit Care Med 25 (1997) 1986-1989
10. Goetz A.M., Wagner M.M., Miller J.M., and Muder R.R. Risk of infection due to central venous catheters: Effect of site of placement and catheter type. Infect Control Hosp Epidemiol 19 (1986) 842-845
11. Merrer J., De Jonghe B., Golliot F., Lefrant J.Y., Raffy B., and Barre E. Complications of femoral and subclavian venous catheterization in critically ill patients. JAMA 286 (2001) 700-707
12. Lorente L., Henry C., Martin M.M., Jiménez A., and Mora M.L. Central venous catheter-related infection in a prospective and observational study of 2595 catheters. Critical Care 9 (2005) R631-R635
13. Deshpande K.S., Hatem C., Ulrich H.L., Currie B.P., Aldrich T.K., Bryan-Brown C.W., et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med 33 (2005) 13-20
14. Nagashima G., Kikuchi T., Tsuyuzaki H., Kawano R., Tanaka H., Nemoto H., et al. To reduce catheter-related bloodstream infections: Is the subclavian route better than the jugular route for central venous catheterization?. J Infect Chemother 12 (2006) 363-365
15. Gowardman J.R., Robertson I.K., Parkes S., and Rickard C.M. Influence of insertion site on central venous catheter colonization and bloodstream infection rates. Intensive Care Med 34 (2008) 1038-1045
16. Garnacho-Montero J., Aldabó-Pallás T., Palomar-Martínez M., Vallés J., Almirante B., Garcés R., et al. Risk factors and prognosis of catheter-related bloodstream infection in critically ill patients: A multicenter study. Intensive Care Med 34 (2008) 2185-2193
17. Lorente L., Lecuona M., Ramos M.J., Jiménez A., Mora M.L., and Sierra A. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia. Clin Infect Dis 47 (2008) 1171-1175
18. Pinilla J.C., Ross D.C., Martin T., and Crump H. Study of the incidence of intravascular catheter infection and associated septicaemia in critically ill patients. Crit Care Med 11 (1983) 21-25
19. Sitzmann J.V., Townsend T.R., Siler M.C., and Bartlett J.G. Septic and technical complications of central venous catheterization. A prospective study of 200 consecutive patients. Ann Surg 202 (1985) 766-770
20. Damen J., Verhoef J., Bolton D.T., Middleton N.G., Van der Tweer I., and Jonge K.D. Microbiologic risk of invasive hemodynamic monitoring in patients undergoing open-heart operation. Crit Care Med 13 (1985) 548-555
21. Brun-Buisson C., Abrouk F., Legrand P., Huet Y., Larabi S., and Rapin M. Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. Arch Intern Med 147 (1987) 873-877
22. Schillinger F., Schillinger D., Montagnac R., and Milcent T. Central venous stenosis in hemodialysis: Comparative angiographic study of subclavian and internal jugular access. Nephrologie 15 (1994) 129-131
23. Álvarez-Lerma F., Palomar M., Olaechea P., Otal J.J., Insausti J., Cerdá E., and Grupo de Estudio de Vigilacia de Infección Nosocomial en UCI. National Study of Control of Nosocomial Infection in Intensive Care Units. Evolutive report of the years 2003-2005. Med Intensiva 31 (2007) 6-17
24. Spengler R.F., and Greenough W.B. Hospital costs and mortality attributed to nosocomial bacteremias. JAMA 240 (1978) 2455-2458
25. Haley R.W., Schaberg D.R., Crossley K.B., Von Allmen S.D., and McGowan J.E. Extra charges and prolongation of hospitalization attributable to nosocomial infections: A prospective interhospital comparison. Am J Med 70 (1981) 51-58
26. Smith R.L., Meixler S.M., and Simberkoff M.S. Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 100 (1991) 164-167
27. Collignon P.J. Intravascular catheter associated sepsis: A common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust 161 (1994) 374-378
28. Pittet D., Tarara D., and Wenzel R. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs and attributable mortality. JAMA 271 (1994) 1598-1601
29. Laupland K.B., Lee H., Gregson D.B., and Manns B.J. Cost of intensive care unit-acquired bloodstream infections. J Hosp Infect 63 (2006) 124-132
30. Arnow P.M., Quimosing E.M., and Beach M. Consequences of intravascular catheter sepsis. Clin Infect Dis 16 (1993) 778-784
31. Pearson M.L. Guideline for prevention of intravascular device-related infections. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control 24 (1996) 262-293
32. O′Grady N.P., Alexander M., Dellinger E.P., Gerberding J.L., Heard S.O., Maki D.G., et al., Centers for Disease Control and Prevention. Guidelines for the Prevention of Intravascular Catheter-Related Infections. MMWR 51 (2002) 1-29
33. León C., Ariza J., SEIMC, and SEMICYUC. Guidelines for the treatment of short-term intravascular catheter-related infections in adults; SEIMC-SEMICYUC Consensus Conference. Enferm Infecc Microbiol Clin 22 (2004) 92-101
34. Pronovost P., Needham D., Berenholtz S., Sinopoli D., Chu H., Cosgrove S., et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 355 (2006) 2725-2732
35. Warren D.K., Cosgrove S.E., Diekema D.J., Zuccotti G., Climo M.W., Bolon M.K., et al., Prevention Epicenter Program. A multicenter intervention to prevent catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 27 (2006) 662-669
36. Marschall J., Mermel L.A., Classen D., Arias K.M., Podgorny K., Anderson D.J., et al. Practice Recommendation of Society for Healthcare Epidemiology of America/Infectious Diseases Society of America (SHEA/IDSA). Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 29 (2008) S22-S30
37. Vanholder R., Lameire N., Verbanck J., Van Rattinghe R., Kunnen M., and Ringoir S. Complications of subclavian catheter hemodialysis: A 5 year prospective study in 257 consecutive patients. Int J Artif Organs 5 (1982) 297-303
38. Vanherweghem J.L., Yassine T., Goldman M., Vandenbosch G., Delcour C., Struyven J., et al. Subclavian vein thrombosis: A frequent complication of subclavian vein cannulation for hemodialysis. Clin Nephrol 26 (1986) 235-238
39. Barrett N., Spencer S., McIvor J., and Brown E.A. Subclavian stenosis: A major complication of subclavian dialysis catheters. Nephrol Dial Transplant 3 (1988) 423-425
40. Brady H.R., Fitzcharles B., Goldberg H., Huraib S., Richardson T., Simons M., et al. Diagnosis and management of subclavian vein thrombosis occurring in association with subclavian cannulation for hemodiálisis. Blood Purif 7 (1989) 210-217
41. Mansfield P.F., Hohn D.C., Fornage B.D., Gregurich M.A., and Ota D.M. Complications and failures of subclavian-vein catheterization. N Engl J Med 331 (1994) 1735-1738
42. Smith H.O., DeVictoria C.L., Garfinkel D., Anderson P., Goldberg G.L., Soeiro R., et al. A prospective randomized comparison of an attached silver-impregnated cuff to prevent central venous catheter-associated infection. Gynecol Oncol 58 (1995) 92-100
43. Lund G.B., Trerotola S.O., Scheel Jr. P.F., Savader S.J., Mitchell S.E., Venbrux A.C., et al. Outcome of tunneled hemodialysis catheters placed by radiologists. Radiology 198 (1996) 467-472
44. Aldrighetti L., Paganelli M., Arru M., Caterini R., Ronzoni M., and Ferla G. Complications of blind placement technique in 980 subcutaneous infusion ports. J Vasc Access 1 (2000) 28-32
45. Lefrant J.Y., Muller L., De La Coussaye J.E., Prudhomme M., Ripart J., and Gouzes C. Risk factors of failure and immediate complication of subclavian vein catheterization in critically ill patients. Intensive Care Med 28 (2002) 1036-1041
46. Canaud B., Beraud J.J., Joyeux H., and Mion C. Internal jugular vein cannulation using 2 silastic catheters. A new, simple and safe long-term vascular access for extracorporeal treatment. Nephron 43 (1986) 133-138
47. Donnelly P.K., Hoenich N.A., Lennard T.W., Proud G., and Taylor R.M. Surgical management of long-term central venous access in uraemic patients. Nephrol Dial Transplant 3 (1988) 57-65
48. Cappello M., De Pauw L., Bastin G., Prospert F., Delcour C., Thaysse C., et al. Central venous access for haemodialysis using the Hickman catheter. Nephrol Dial Transplant 4 (1989) 988-992
49. Gibson S.P., Mosquera D.A., O'Donnell M.J., and Odurny A. Streptokinase in the treatment of innominate-vein thrombosis in association with haemodialysis catheter. Preservation of a precious arteriovenous fistula. Nephrol Dial Transplant 6 (1991) 206-208
50. Kaiser C.W., Koornick A.R., Smith N., and Soroff H.S. Choice of route for central venous cannulation: Subclavian or internal jugular vein? A prospective randomized study. J Surg Oncol 17 (1981) 345-354
51. Bo-Linn G.W., Anderson D.J., Anderson K.C., and McGoon M.D. Percutaneous central venous catheterization performed by medical house officers: A prospective study. Cathet Cardiovasc Diagn 8 (1982) 23-29
52. Eisenhauer E.D., Derveloy R.J., and Hastings P.R. Prospective evaluation of central venous pressure (CVP) catheters in a large city-county hospital. Ann Surg 196 (1982) 560-564
53. Sessler C.N., and Glauser F.L. Central venous cannulation done by house officers in the intensive care unit: A prospective study. South Med J 80 (1987) 1239-1242
54. Cimochowski G.E., Worley E., Rutherford W.E., Sartain J., Blondin J., and Harter H. Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron 54 (1990) 154-161
55. Peres P.W. Positioning central venous catheters-a prospective survey. Anaesth Intensive Care 18 (1990) 536-539
56. Barrera R., Mina B., Huang Y., and Groeger J.S. Acute complications of central line placement in profoundly thrombocytopenic cancer patients. Cancer 78 (1996) 2025-2030
57. Luyt D.K., Mathivha L.R., Litmanovitch M., Dance M.D., and Brown J.M. Confirmation of the safety of central venous catheterisation in critically ill infants and children-the Baragwanath experience. S Afr Med J 86 (1996) 603-606
58. Fisher N.C., and Mutimer D.J. Central venous cannulation in patients with liver disease and coagulopathy-a prospective audit. Intensive Care Med 25 (1999) 481-485
59. Miller J.A., Singireddy S., Maldjian P., and Baker S.R. A reevaluation of the radiographically detectable complications of percutaneous venous access lines inserted by four subcutaneous approaches. Am Surg 65 (1999) 125-130
60. Williams J.F., Seneff M.G., Friedman B.C., McGrath B.J., Gregg R., Sunner J., et al. Use of femoral venous catheters in critically ill adults: Prospective study. Crit Care Med 19 (1991) 550-553
61. Timsit J.F., Bruneel F., Cheval C., Mamzer M.F., Garrouste-Orgeas M., Wolff M., et al. Use of tunneled femoral catheters to prevent catheter-related infection. A randomized, controlled trial. Ann Intern Med 130 (1999) 729-735
62. Iovino F., Pittiruti M., Buononato M., and Lo Schiavo F. Central venous catheterization: Complications of different placements. Ann Chir 126 (2001) 1001-1006
63. Eisen L.A., Narasimhan M., Berger J.S., Mayo P.H., Rosen M.J., and Schneider R.F. Mechanical complications of central venous catheters. J Intensive Care Med 21 (2006) 40-46
64. Schummer W., Schummer C., Rose N., Niesen W.D., and Sakka S.G. Mechanical complications and malpositions of central venous cannulations by experienced operators. A prospective study of 1794 catheterizations in critically ill patients. Intensive Care Med 33 (2007) 1055-1059
65. Bagwell C.E., Salzberg A.M., Sonnino R.E., and Haynes J.H. Potentially lethal complications of central venous catheter placement. J Pediatr Surg 35 (2000) 709-713
66. Veenstra D.L., Saint S., Saha S., Lumley T., and Sullivan S.D. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: A meta-analysis. JAMA 281 (1999) 261-267
67. Marin M.G., Lee J.C., and Skurnick J.H. Prevention of nosocomial bloodstream infections: Effectiveness of antimicrobial-impregnated and heparin-bonded central venous catheters. Crit Care Med 28 (2000) 3332-3338
68. Falagas M.E., Fragoulis K., Bliziotis I.A., and Chatzinikolaou I. Rifampicin-impregnated central venous catheters: A meta-analysis of randomized controlled trials. J Antimicrob Chemother 59 (2007) 359-369
69. Casey A.L., Mermel L.A., Nightingale P., and Elliott T.S. Antimicrobial central venous catheters in adults: A systematic review and meta-analysis. Lancet Infect Dis 8 (2008) 763-776
70. León C., Ruiz-Santana S., Rello J., De la Torre M.V., Vallés J., Álvarez-Lerma F., et al., Cabaña Study Group. Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial. Intensive Care Med 30 (2004) 1891-1899
71. Fraenkel D., Rickard C., Thomas P., Faoagali J., George N., and Ware R. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. Crit Care Med 34 (2006) 668-675
72. Chatzinikolaou I., Finkel K., Hanna H., Boktour M., Foringer J., Ho T., et al. Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: A prospective, randomized study. Am J Med 115 (2003) 352-357
73. Lorente L., Jiménez A., García C., Galván R., Castedo J., Martín M.M., et al. Catheter-related bacteremia from femoral and central internal jugular venous access. Eur J Clin Microbiol Infect Dis 27 (2008) 867-871
74. Lorente L., Jiménez A., Castedo J., Galván R., García C., Martín M.M., et al. Internal jugular venous catheter-related bacteremia according to central and posterior accesses. Intensive Care Med 33 (2007) 1071-1075
75. Lorente L., Jiménez A., Galván R., García C., Castedo J., Martín M.M., et al. Equivalence of posterior internal jugular and subclavian accesses in the incidence of central venous catheter related bacteremia. Intensive Care Med 33 (2007) 2230-2231
76. Lorente L., Jiménez A., Iribarren J.L., Jiménez J.J., Martín M.M., and Mora M.L. The micro-organism responsible for central venous catheter related bloodstream infection depends on catheter site. Intensive Care Med 32 (2006) 1449-1450
77. Lorente L., Jiménez A., Santana M., Iribarren J.L., Jiménez J.J., Martín M.M., et al. Microorganisms responsible for intravascular catheter-related bloodstream infection according to the catheter site. Crit Care Med 35 (2007) 2424-2427
78. Lorente L., Jiménez A., and Mora M.L. Microorganisms responsibles for femoral catheter-related bloodstream infection. Crit Care Med 36 (2008) 657-658
79. Lisboa T., and Rello J. Prevention of nosocomial infections: Strategies to improve the safety of the patients in the Intensive Care Unit. Med Intensiva 32 (2008) 248-252